PUTRAJAYA: The Covid-19 Vaccine Pharmacovigilance Special Committee's evaluation of 25 reports of adverse events following immunisation (AEFI), which involved deaths among recipients of the booster dose, found that the fatalities were unrelated to the vaccine received.
National Pharmaceutical Regulatory Agency (NPRA) director Dr Roshayati Mohamad Sani said the 25 reports were out of the 56 AEFI reports involving deaths among recipients of the booster dose vaccine that was received by the NPRA for investigation and evaluation.